Dhuwit awis saben lembar saham Regulus (RGLS)

Simbol lan logo merek Regulus (RGLS)

Combating rare nephrological pathologies requires alliances with pharma behemoths, which is reflected in the cash per share reserves of Regulus Therapeutics (RGLS). The value of 0.94 expresses the metric level, confirming liquidity for R&D. Fixed costs for RNA drugs will create powerful leverage following FDA approval, while operations remain strictly limited by medical regulations regarding the disposal of biomaterials.

RGLS Regulus Therapeutics Inc.: Dhuwit awis saben siji saham ing interval 04.07.2022 - 05.07.2025

Rincian metrik komprehensif lan analitis Regulus Therapeutics, Inc. (RGLS)

- rega lan prakiraan konsensus rega:
- data dhuwit lan arus kas:
Ringkesan analisis perusahaan:RGLS Regulus
Produk dadi Regulus Therapeutics Inc.

Cash per share determines the portion of liquid assets attributable to a single security, serving as a baseline for capital protection. For Regulus Therapeutics (RGLS), this resource is critical for funding clinical trials of RNA therapies for kidney diseases. The trend in cash per share reflects the burn rate of the budget allocated to pipeline development. A stable balance confirms the issuer's solvency prior to securing partnerships with pharma behemoths. This indicator provides an objective assessment of the company's financial cushion.

Analisis perusahaan pesaing

TEM (Tempus AI Inc) - Dhuwit awis diétung saben siji saham|Dhuwit awis saben saham QGEN|IONS - Cekelan dhuwit saben saham|Dana dhuwit saben saham Repligen RGEN|RNA: Dana dhuwit saben siji saham|CRSP: Dhuwit awis saben siji saham|GeneDx Corp (WGS) - Dhuwit awis saben siji saham|RARE: Dhuwit awis saben saham|BEAM - Dana dhuwit diétung saben saham|SRPT (Sarepta Therapeutics) - Dhuwit awis saben saham|Dhuwit awis saben siji saham Twist Bioscience Inc (TWST)|Dhuwit awis saben saham TXG|Dana dhuwit diétung saben saham Intellia|Stoke - Dhuwit awis saben siji saham|BLFS: Dana dhuwit saben siji saham|Wave Life Sciences Corp - Dhuwit awis saben saham|Maze Therapeutics, Inc. (MAZE) - Dhuwit awis saben siji saham|Sionna Therapeutics Inc (SION) - Dana dhuwit saben saham|Dhuwit awis saben siji saham Prime Medicine Corp|Dana dhuwit saben saham tayshagtx.com|QURE - Volume dana dhuwit saben saham|Dhuwit awis saben siji saham MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Volume dana dhuwit saben saham|Dhuwit awis saben saham SLDB (Solid Biosciences Inc.)|Gunggung dhuwit awis saben saham OCGN|PacBio Corp - Dhuwit awis saben saham|Benitec Biopharma Inc. (BNTC) - Dhuwit awis saben siji saham|DSGN: Dhuwit awis saben saham|Dana dhuwit saben siji saham RCKT|Dhuwit awis saben siji saham FDMT|Dana dhuwit saben siji saham LXEO (Lexeo Therapeutics)|Dhuwit awis saben saham KRRO|Editas Medicine, Inc. - Dana dhuwit saben siji saham|Dana dhuwit saben saham Silence Therapeutics Inc. SLN|Dhuwit awis saben saham ProQR Therapeutics N.V. PRQR|CDXS: Dhuwit awis saben siji saham|Volume dana dhuwit saben saham Sangamo (SGMO)|NAUT (Nautilus Bio) - Dhuwit awis saben siji saham|MGX - Dana dhuwit diétung saben saham|DTIL (Precision BioSciences Inc.) - Dhuwit awis saben saham|generationbio.com (GBIO) - Dana dhuwit diétung saben saham|Dana dhuwit saben saham Boundless Bio Inc (BOLD)|Dhuwit awis saben saham Exicure Inc. (XCUR)|Dana dhuwit saben saham imunon.com IMNN|Dhuwit awis saben saham Phio Pharmaceuticals PHIO|Mustang Bio Inc - Dhuwit awis saben saham|Cekelan dhuwit saben saham transcodetherapeutics.com|BNGO: Dhuwit awis saben saham|Dana dhuwit saben siji saham APDN|BLUE (bluebirdbio.com) - Dhuwit awis saben saham|Cekelan dhuwit saben saham ImmunoPrecise Antibodies IPA|Dhuwit awis saben siji saham OMGA (omegatherapeutics.com)|Dhuwit awis saben saham Singular Genomics Systems, Inc. (OMIC)|Dhuwit awis saben saham SYRS (Syros Pharmaceuticals Inc.)|Dhuwit awis diétung saben siji saham TBIO (Codex DNA)|TCON - Dana dhuwit saben saham|Cekelan dhuwit saben saham Unity Biotechnology